Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY

Nattawat Klomjit, Ladan Zand

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)1702-1705
Number of pages4
JournalKidney360
Volume2
Issue number11
DOIs
StatePublished - Nov 1 2021
Externally publishedYes

Keywords

  • MN
  • Ponticelli regimen
  • cyclophosphamide
  • glomerular and tubulointerstitial diseases
  • glomerulonephritis
  • membranous
  • membranous nephropathy
  • rituximab

Cite this